Schizotrin A; a novel antimicrobial cyclic peptide from a cyanobacterium

doi:10.1016/S0040-4039(00)74436-4

Tetrahedron Letters

Volume 35, Issue 45, 7 November 1994, Pages 8473-8476

https://doi.org/10.1016/S0040-4039(00)74436-4 Get rights and content

Abstract

A novel cyclic undecapeptide, Schizotrin A, possessing moderately strong antimicrobial activity is the major active metabolite in the cultured cyanobacterium Schizotrix sp. (TAU strain IL-89-2). The gross structure of Schizotrin A (1) was determined mainly by homonuclear- and inverse-heteronuclear-2D-NMR techniques and HRFABMS.

A novel antimicrobial cyclic undecapeptide, schizotrin A, is the major active metabolite in the cultured cyanobacterium Schizotrix sp.

References (12)

W.W. Carmichael
J. Appl. Bacteriol.
(1992)
D.C. Carter et al.
J. Org. Chem.
(1984)
G.L. Helms et al.
J. Org. Chem.
(1988)
R.E. Moore et al.
J. Am. Chem. Soc.
(1989)
S.-S. Moon et al.
J. Org. Chem.
(1992)
W.F. Frankmolle et al.
J. Antibiotics
(1992)

There are more references available in the full text version of this article.

Cited by (64)

Cyanobacteria-based microbial cell factories for production of industrial products
2021, Microbial Cell Factories Engineering for Production of Biomolecules
Cyanobacteria are microscopic microorganisms, unicellular or multicellular oxygenic photoautotrophs, and Gram-negative prokaryotes, widespread in terrestrial or aquatic environment and mostly occur in fresh water and marine environment. They have greatest diversity and morphology among all prokaryotes. They are the principal producers of biomass in the world and produce a huge number of natural bioactive products including indoles, toxins, amides, macrolides, lipopeptides, fatty acids, polyketides, amino acids and alkaloids, bioplastics, coloring dyes, enzymes, and many drugs. So, they showed great potential applications in remediation and production of biodiesel, biohydrogen, and bioplastic. They are also used in the synthesis of various nanoparticles such as silver, gold, lead, platinum, and zinc oxide. Cyanobacteria are used as source of natural pigment that can be benefits in many industries such as chlorophyll a uses in manufacture of pharmaceutical and cosmetics, Phycobiliproteins use in manufacture of immunofluorescence techniques, antibody labeling food colorant (ice cream and sweets), cosmetics, immunofluorescence techniques; antibody labeling, carotenoids use in manufacture of antioxidant, anticancer, antiobesity, antiproliferative activity, antiproliferative, and antiinflammatory. This chapter focuses on the advantages of cyanobacteria in many application processes.
Antibacterial and antiviral metabolites from cyanobacteria: Their application and their impact on human health
2021, Current Research in Biotechnology
Bacterial and viral infections pose a direct threat to human health due to the increase of drug-resistant and novel pathogenic strains. Natural products represent a prolific source of bioactive metabolites, which have been exploited for their therapeutic effects. In particular, cyanobacteria were identified as important producers of secondary metabolites possessing antibacterial and antiviral activities, among others. A meta-analysis indicated that some natural product classes target bacteria or viruses exclusively. This result also applied for some cyanobacterial species that were identified to produce only antibacterial or antiviral compounds. Furthermore, cyanobacteria represent a promising host for bio-production due to their ability to perform photosynthesis and their low-cost production requirements. This review highlights antibacterial and antiviral compounds isol isolated from cyanobacteria and the biotechnological application of these organisms .
Bioactive molecules from microalgae and constraints in commercialization
2020, Natural Bioactive Compounds: Technological Advancements
Increasing drug resistance in pathogenic microorganisms especially fungi and bacteria, menace caused by AIDS in modern society, spread of dreaded cancer disease worldwide, especially in third-world countries led the scientists to look at nature and little explored microalgae which seem to be a bioresource for biomolecules. Microalgae, in general, involve all microscopic algae including cyanobacteria which have originated on earth ̴2.8 billion years ago. Modern knowledge of genomics, proteomics and understanding of the strategy of survival of such microalgal strains inhabiting various environments including extreme habitats must be endowed with specific metabolic pathways, producing specific biomolecules of synthetic biochemist's interest. Bioassays of microalgal extracts clearly demonstrate their potential to kill fungi and bacteria and to inhibit growth of viral and cancer cells. The identification of target biomolecules is a difficult task. Modern instruments including chromatography and high-resolution mass spectrometry led to the isolation and identification of biomolecules. However, small quantities of biomolecules (μg/g dry weight) made it difficult to produce at large scale. This chapter reviews the state of the art in extraction, purification and extent of nanotechnology for its impact on microbial system as well as cancer cells. Constraints in commercialization of biomolecules and drug production and its overcoming strategies are also discussed.
Cyanobacteria: Applications in Biotechnology
2018, Cyanobacteria: From Basic Science to Applications
Cyanobacteria, the first oxygen-evolving group of photosynthetic Gram-negative prokaryotes, are unique among microbial world and grow in diverse habitats. Cyanobacteria synthesize a vast array of novel secondary metabolites including biologically active compounds with antibacterial, antiviral, antifungal, and anticancer activities. Certain other important metabolites reported from cyanobacteria, include enzymes, toxins, UV-absorbing pigments, and certain fluorescent dyes. Furthermore, biofuel production by cyanobacteria constitutes one of the most promising areas for biotechnological applications. In addition, production of alcohols and isoprenoids, biopolymers, recombinant proteins, and single-cell protein employing modern tools of genetic engineering seems attractive. In the field of agriculture, potent N₂-fixing cyanobacteria could be exploited as bio-factory to produce biofertilizer for enriching the fertility of soil. There is a need to develop suitable genome engineering tools in cyanobacteria to produce fuels, value-added compounds, and feedstocks in a sustainable way. In this chapter, an overview of the potential applications of cyanobacteria in various sectors of biotechnology is presented.
Antibacterial, antifungal and antimycobacterial compounds from cyanobacteria
2017, Biomedicine and Pharmacotherapy
Infections from multidrug resistant (MDR) pathogenic bacteria, fungi and Mycobacterium tuberculosis remain progressively intractable. The search of effective antimicrobials from other possible non-conventional sources against MDR pathogenic bacteria, fungi and mycobacteria is call of the day. This review considers 121 cyanobacterial compounds or cyano-compounds with antimicrobial activities. Chemical structures of cyano-compounds were retrieved from ChemSpider and PubChem databases and were visualized by the software ChemDraw Ultra. Chemical information on cyano-compounds pertaining to Lipinski rules of five was assessed. The reviewed cyano-compounds belong to the following chemical classes (with examples): alkaloids (ambiguine isonitriles and 12-epi-hapalindole E isonitrile), aromatic compounds (benzoic acid and cyanobacterin), cyclic depsipeptides (cryptophycin 52 and lyngbyabellin A), cyclic peptides (calophycin and tenuecyclamides), cyclic undecapeptides (kawaguchipeptins and lyngbyazothrin A), cyclophane (carbamidocyclophane), extracellular pigment (nostocine A), fatty acids (alpha-dimorphecolic acid and majusculonic acid), linear peptides (muscoride A), lipopeptides (fischerellins and scytonemin A), nucleosides (tolytoxin and tubercidin), phenols (ambigols and 4-4′-hydroxybiphenyl), macrolides (scytophycin A and tolytoxin), polyketides (malyngolide and nostocyclyne), polyphenyl ethers (crossbyanol A), porphinoids (tolyporphin J) and terpenoids (noscomin and scytoscalarol). Cyanobacteria appear to be a diverse source of compounds with antimicrobial activity. Further attention is required to elucidate whether those could be applied as pharmaceuticals.
Microseiramide from the freshwater cyanobacterium Microseira sp. UIC 10445
2015, Phytochemistry Letters
Citation Excerpt :
Compounds structurally related to lyngbyazothrins A–D have also been reported from strains that are morphologically similar to Lyngbya. These compounds include schizotrin A isolated from Schizotrix sp. (TAU strain IL-89-2) (Pergament and Carmeli, 1994), pahayokolides A and B isolated from a marine Lyngbya sp. (An et al., 2007), tychonamides A and B isolated from a Tychonema sp. (Mehner et al., 2008), and portoamides A–D isolated from Oscillatoria sp. LEGE 5292 (Leao et al., 2010).
Microseiramide (1), a cyclic heptapeptide, was isolated from a sample of the freshwater cyanobacterium Microseira sp. UIC 10445 collected in a shallow lake in Northern Indiana. Taxonomic identification of UIC 10445 was performed by a combination of morphological and phylogenetic characterization. Phylogenetic analysis revealed that UIC 10445 was a member of the recently described genus Microseira, which is phylogenetically distinct from the morphologically similar genera, Moorea and Lyngbya. The planar structure of microseiramide (1) was determined by extensive 1D and 2D NMR experiments as well as HRESIMS analysis. The absolute configurations of amino acid residues were determined using acid hydrolysis followed by the advanced Marfey’s analysis. Microseiramide (1) is the first cyclic peptide reported from a Microseira sp., and the structure of microseiramide (1) is distinct from the previously known metabolites from cyanobacteria of the genera Moorea and Lyngbya.

View all citing articles on Scopus

View full text

Schizotrin A; a novel antimicrobial cyclic peptide from a cyanobacterium

Abstract

J. Appl. Bacteriol.

J. Org. Chem.

J. Org. Chem.

J. Am. Chem. Soc.

J. Org. Chem.

J. Antibiotics